| Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD) M Yoneda, H Mawatari, K Fujita, H Endo, H Iida, Y Nozaki, K Yonemitsu, ... Digestive and Liver Disease 40 (5), 371-378, 2008 | 536 | 2008 |
| Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial K Hosono, H Endo, H Takahashi, M Sugiyama, E Sakai, T Uchiyama, ... Cancer prevention research 3 (9), 1077-1083, 2010 | 409 | 2010 |
| High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH M Yoneda, H Mawatari, K Fujita, H Iida, K Yonemitsu, S Kato, ... Journal of gastroenterology 42, 573-582, 2007 | 388 | 2007 |
| Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) M Yoneda, K Fujita, M Inamori, A Nakajima, M Tamano, H Hiraishi Gut 56 (9), 1330-1331, 2007 | 341 | 2007 |
| Dysfunctional very‐low‐density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis K Fujita, Y Nozaki, K Wada, M Yoneda, Y Fujimoto, M Fujitake, H Endo, ... Hepatology 50 (3), 772-780, 2009 | 295 | 2009 |
| Metformin suppresses azoxymethane‐induced colorectal aberrant crypt foci by activating AMP‐activated protein kinase K Hosono, H Endo, H Takahashi, M Sugiyama, T Uchiyama, K Suzuki, ... Molecular carcinogenesis 49 (7), 662-671, 2010 | 232 | 2010 |
| Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition T Fujisawa, H Endo, A Tomimoto, M Sugiyama, H Takahashi, S Saito, ... Gut 57 (11), 1531-1538, 2008 | 214 | 2008 |
| Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus. T Iwasaki, M Yoneda, M Inamori, J Shirakawa, T Higurashi, S Maeda, ... Hepato-gastroenterology 58 (112), 2103-2105, 2011 | 182 | 2011 |
| Oral administration of lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance JUNI TOGAWA, H Nagase, K Tanaka, M Inamori, A Nakajima, N Ueno, ... Journal of gastroenterology and hepatology 17 (12), 1291-1298, 2002 | 181 | 2002 |
| Clinical factors predictive of spontaneous remission or relapse in cases of autoimmune pancreatitis K Kubota, H Iida, T Fujisawa, M Yoneda, M Inamori, Y Abe, H Kirikoshi, ... Gastrointestinal endoscopy 66 (6), 1142-1151, 2007 | 174 | 2007 |
| Evidence-based clinical practice guidelines for irritable bowel syndrome S Fukudo, H Kaneko, H Akiho, M Inamori, Y Endo, T Okumura, ... Journal of Gastroenterology 50 (1), 11-30, 2015 | 168 | 2015 |
| Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study H Endo, T Higurashi, K Hosono, E Sakai, Y Sekino, H Iida, Y Sakamoto, ... Journal of gastroenterology 46, 894-905, 2011 | 163 | 2011 |
| Sporadic nonampullary duodenal adenoma in the natural history of duodenal cancer: a study of follow-up surveillance K Okada, J Fujisaki, A Kasuga, M Omae, M Kubota, T Hirasawa, ... Official journal of the American College of Gastroenterology| ACG 106 (2 …, 2011 | 161 | 2011 |
| Efficacy of ezetimibe for the treatment of non‐alcoholic steatohepatitis: an open‐label, pilot study M Yoneda, K Fujita, Y Nozaki, H Endo, H Takahashi, K Hosono, K Suzuki, ... Hepatology Research 40 (6), 566-573, 2010 | 155 | 2010 |
| Long-term outcomes of endoscopic submucosal dissection for undifferentiated-type early gastric cancer K Okada, J Fujisaki, T Yoshida, H Ishikawa, T Suganuma, A Kasuga, ... Endoscopy 44 (02), 122-127, 2012 | 150 | 2012 |
| Evidence-based clinical practice guidelines for irritable bowel syndrome 2020 S Fukudo, T Okumura, M Inamori, Y Okuyama, M Kanazawa, T Kamiya, ... Journal of gastroenterology 56 (3), 193-217, 2021 | 145 | 2021 |
| Lactoferrin reduces colitis in rats via modulation of the immune system and correction of cytokine imbalance JI Togawa, H Nagase, K Tanaka, M Inamori, T Umezawa, A Nakajima, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 283 (1 …, 2002 | 135 | 2002 |
| Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease K Fujita, Y Nozaki, K Wada, M Yoneda, H Endo, H Takahashi, T Iwasaki, ... Gut 57 (11), 1583-1591, 2008 | 124 | 2008 |
| Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH) M Yoneda, T Uchiyama, S Kato, H Endo, K Fujita, K Yoneda, H Mawatari, ... BMC gastroenterology 8, 1-9, 2008 | 122 | 2008 |
| Outcomes and factors influencing survival in cirrhotic cases with spontaneous rupture of hepatocellular carcinoma: a multicenter study H Kirikoshi, S Saito, M Yoneda, K Fujita, H Mawatari, T Uchiyama, ... BMC gastroenterology 9, 1-9, 2009 | 118 | 2009 |
